You may report an adverse event by telephone at +49 6131 90840 or use the following web form.
Adverse events that occur as part of a clinical trial must be reported to the appropriate coordinating study center.
If you are suffering, or the person on whose behalf you are reporting is currently suffering from a serious adverse event, you should contact your physician or other healthcare professional before reporting the adverse event.
The products listed here may have different methods of approval depending on country.
Do you have a medical inquiry regarding our COVID-19 mRNA vaccine (BNT162)? In that
case, please use this website (https://pro.biontech.de/) and choose your relevant country.
BioNTech Medical Information processes your personal information to address or provide a response to your medical inquiry and – if applicable – for drug safety surveillance. We may share your information with other BioNTech colleagues to ensure that your inquiry is addressed appropriately. Your name, contact details and job title will be shared with our pharmacovigilance team if you disclose an adverse event, i.e. side-effects of a drug so that they can contact you regarding the adverse event. It may be necessary for us to share your information with BioNTech`s affiliates, business partners, service providers and regulatory authorities located in countries besides your own, potentially including countries outside of the EU/EEA, to the extent required to comply with applicable statutory reporting obligations. BioNTech has implemented measures to protect the personal information you provide.
We will retain your personal information only for as long as we are communicating with you, unless a longer retention period is required or permitted by law or industry best practice. Art. 9 (2) (i) and Art. 6 (1) (c) GDPR in conjunction with applicable Union or Member State statutory reporting obligations serve as legal bases for the described data processing. All personal information you share with us will be protected and kept confidential in accordance with BioNTech’s data privacy policy (link). If you have any further questions about the use of your personal information, please contact us.